| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 4.39e-05 | 14 | 101 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 7.57e-05 | 3 | 101 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.71e-04 | 308 | 101 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | kinetochore binding | 3.75e-04 | 6 | 101 | 2 | GO:0043515 | |
| GeneOntologyBiologicalProcess | organelle assembly | CDC14C CFAP47 CDS1 ABCC4 RPGRIP1L TBC1D30 CENPE CENPF RB1CC1 NEB CDC14B AKAP4 NF2 CFAP221 MLH1 PRKAR1A CC2D2A CDK5RAP2 CEP295 CNOT1 | 3.23e-07 | 1138 | 98 | 20 | GO:0070925 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic nuclear division | 5.91e-07 | 64 | 98 | 6 | GO:0045839 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear division | 1.30e-06 | 73 | 98 | 6 | GO:0051784 | |
| GeneOntologyBiologicalProcess | regulation of chromosome separation | 2.07e-06 | 79 | 98 | 6 | GO:1905818 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CDC14C CFAP47 KIF21B SEMG2 CENPE APOB CNTLN TTK CDC14B AKAP4 DST CFAP221 KIF19 VPS13A MLH1 CC2D2A CDK5RAP2 CEP295 | 2.19e-06 | 1058 | 98 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | chromosome separation | 3.90e-06 | 88 | 98 | 6 | GO:0051304 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly checkpoint signaling | 4.32e-06 | 51 | 98 | 5 | GO:0007094 | |
| GeneOntologyBiologicalProcess | spindle assembly checkpoint signaling | 4.32e-06 | 51 | 98 | 5 | GO:0071173 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | TBC1D30 CENPE CENPF TOM1L1 ARHGEF18 TTK USP44 TBC1D4 VILL XRN1 CDK5RAP2 | 5.12e-06 | 421 | 98 | 11 | GO:0010639 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic metaphase/anaphase transition | 5.23e-06 | 53 | 98 | 5 | GO:0045841 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid segregation | 5.23e-06 | 53 | 98 | 5 | GO:0033048 | |
| GeneOntologyBiologicalProcess | negative regulation of sister chromatid segregation | 5.23e-06 | 53 | 98 | 5 | GO:0033046 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid separation | 5.23e-06 | 53 | 98 | 5 | GO:2000816 | |
| GeneOntologyBiologicalProcess | mitotic spindle checkpoint signaling | 5.23e-06 | 53 | 98 | 5 | GO:0071174 | |
| GeneOntologyBiologicalProcess | negative regulation of metaphase/anaphase transition of cell cycle | 6.30e-06 | 55 | 98 | 5 | GO:1902100 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome separation | 6.30e-06 | 55 | 98 | 5 | GO:1905819 | |
| GeneOntologyBiologicalProcess | spindle checkpoint signaling | 7.52e-06 | 57 | 98 | 5 | GO:0031577 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome segregation | 7.52e-06 | 57 | 98 | 5 | GO:0051985 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 9.70e-06 | 60 | 98 | 5 | GO:0033047 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 1.21e-05 | 107 | 98 | 6 | GO:2001251 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid separation | 1.33e-05 | 64 | 98 | 5 | GO:0010965 | |
| GeneOntologyBiologicalProcess | response to interleukin-2 | 1.67e-05 | 11 | 98 | 3 | GO:0070669 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid separation | 1.67e-05 | 67 | 98 | 5 | GO:0051306 | |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 1.98e-05 | 316 | 98 | 9 | GO:0140014 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell differentiation | 2.22e-05 | 12 | 98 | 3 | GO:0032825 | |
| GeneOntologyBiologicalProcess | response to interleukin-15 | 2.22e-05 | 12 | 98 | 3 | GO:0070672 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | CDC14C MYBBP1A CENPE CENPF TOM1L1 SMC2 TTK CDC14B STAT5A STAT5B USP44 ZZZ3 NF2 BRINP2 CDK5RAP2 ANAPC16 CEP295 EXOC7 | 2.30e-05 | 1256 | 98 | 18 | GO:0051726 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | CDC14C CENPE CENPF TOM1L1 TTK CDC14B STAT5A STAT5B USP44 BRINP2 CDK5RAP2 ANAPC16 | 2.48e-05 | 594 | 98 | 12 | GO:0007346 |
| GeneOntologyBiologicalProcess | nuclear division | CDC14C CENPE CENPF TOM1L1 SMC2 TTK CDC14B USP44 SYCP2 MLH1 CDK5RAP2 | 3.17e-05 | 512 | 98 | 11 | GO:0000280 |
| GeneOntologyBiologicalProcess | sperm motility | 3.80e-05 | 193 | 98 | 7 | GO:0097722 | |
| GeneOntologyBiologicalProcess | response to interleukin-4 | 4.24e-05 | 41 | 98 | 4 | GO:0070670 | |
| GeneOntologyBiologicalProcess | regulation of mitotic nuclear division | 4.33e-05 | 134 | 98 | 6 | GO:0007088 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 5.32e-05 | 139 | 98 | 6 | GO:0051983 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TBC1D30 CENPE CENPF VPS13C TOM1L1 ARHGEF18 NEB SMC2 TTK USP44 TBC1D4 NF2 VILL ZDHHC6 XRN1 CDK5RAP2 CEP295 CNOT1 | 5.50e-05 | 1342 | 98 | 18 | GO:0033043 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | 6.01e-05 | 282 | 98 | 8 | GO:0045930 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 6.68e-05 | 3 | 98 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | Golgi to endosome transport | 8.06e-05 | 18 | 98 | 3 | GO:0006895 | |
| GeneOntologyBiologicalProcess | organelle fission | CDC14C CENPE CENPF TOM1L1 SMC2 TTK CDC14B USP44 SYCP2 MLH1 CDK5RAP2 | 8.44e-05 | 571 | 98 | 11 | GO:0048285 |
| GeneOntologyBiologicalProcess | cilium organization | CDC14C CFAP47 ABCC4 RPGRIP1L TBC1D30 CDC14B AKAP4 CFAP221 KIF19 CC2D2A | 8.90e-05 | 476 | 98 | 10 | GO:0044782 |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 9.03e-05 | 95 | 98 | 5 | GO:0030071 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 1.05e-04 | 98 | 98 | 5 | GO:1902099 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 1.09e-04 | 52 | 98 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | maintenance of location | 1.13e-04 | 396 | 98 | 9 | GO:0051235 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 1.15e-04 | 100 | 98 | 5 | GO:0007091 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell activation | 1.15e-04 | 100 | 98 | 5 | GO:0050871 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | CFAP47 KIF21B SEMG2 CENPE APOB AKAP4 DST CFAP221 KIF19 VPS13A | 1.19e-04 | 493 | 98 | 10 | GO:0007018 |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 1.28e-04 | 163 | 98 | 6 | GO:0007093 | |
| GeneOntologyBiologicalProcess | regulation of B cell activation | 1.28e-04 | 163 | 98 | 6 | GO:0050864 | |
| GeneOntologyBiologicalProcess | kinetochore organization | 1.30e-04 | 21 | 98 | 3 | GO:0051383 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell differentiation | 1.30e-04 | 21 | 98 | 3 | GO:0045579 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 1.30e-04 | 21 | 98 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 1.32e-04 | 103 | 98 | 5 | GO:0044784 | |
| GeneOntologyBiologicalProcess | sexual reproduction | CFAP47 SEMG2 ANGPT2 CENPE APOB CNTLN SMC2 TTK ITPR1 SYCP2 AKAP4 CFAP221 PDILT XRN1 MLH1 ANAPC16 SMC1B | 1.39e-04 | 1312 | 98 | 17 | GO:0019953 |
| GeneOntologyBiologicalProcess | lipid storage | 1.45e-04 | 105 | 98 | 5 | GO:0019915 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CDC14C CFAP47 CENPE CNTLN TTK CDC14B DST KIF19 MLH1 CC2D2A CDK5RAP2 CEP295 | 1.56e-04 | 720 | 98 | 12 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 1.72e-04 | 172 | 98 | 6 | GO:0051783 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.88e-04 | 111 | 98 | 5 | GO:0033045 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 2.21e-04 | 5 | 98 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 2.63e-04 | 186 | 98 | 6 | GO:0030317 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 2.65e-04 | 350 | 98 | 8 | GO:0051321 | |
| GeneOntologyBiologicalProcess | cilium assembly | CDC14C CFAP47 ABCC4 RPGRIP1L TBC1D30 CDC14B AKAP4 CFAP221 CC2D2A | 2.65e-04 | 444 | 98 | 9 | GO:0060271 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 2.79e-04 | 266 | 98 | 7 | GO:0033044 | |
| GeneOntologyBiologicalProcess | cell cycle phase | 2.80e-04 | 27 | 98 | 3 | GO:0022403 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 2.92e-04 | 122 | 98 | 5 | GO:0045132 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 2.97e-04 | 356 | 98 | 8 | GO:0098813 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CDC14C CENPE CENPF TOM1L1 SMC2 TTK CDC14B STAT5A STAT5B USP44 BRINP2 CDK5RAP2 ANAPC16 EXOC7 | 3.04e-04 | 1014 | 98 | 14 | GO:0000278 |
| GeneOntologyBiologicalProcess | lipid localization | CDS1 ABCC4 ABCA12 VPS13C TRPC5 APOB STAT5A STAT5B VPS13A ANGPTL3 | 3.55e-04 | 565 | 98 | 10 | GO:0010876 |
| GeneOntologyBiologicalProcess | chromosome organization | CENPE CENPF SMC2 TTK USP44 RIF1 SYCP2 XRN1 MLH1 CDK5RAP2 SMC1B | 4.12e-04 | 686 | 98 | 11 | GO:0051276 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 4.34e-04 | 475 | 98 | 9 | GO:0140694 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-9 | 4.62e-04 | 7 | 98 | 2 | GO:0071355 | |
| GeneOntologyBiologicalProcess | interleukin-9-mediated signaling pathway | 4.62e-04 | 7 | 98 | 2 | GO:0038113 | |
| GeneOntologyBiologicalProcess | cell division | CDC14C CENPE CENPF SMC2 CDC14B USP44 SYCP2 ZZZ3 ANAPC16 DCLRE1A EXOC7 | 4.71e-04 | 697 | 98 | 11 | GO:0051301 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 5.01e-04 | 210 | 98 | 6 | GO:0060294 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 5.27e-04 | 212 | 98 | 6 | GO:0000070 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 5.67e-04 | 215 | 98 | 6 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 5.67e-04 | 215 | 98 | 6 | GO:0001539 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 5.96e-04 | 217 | 98 | 6 | GO:0000075 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell activation | 6.10e-04 | 35 | 98 | 3 | GO:0032816 | |
| GeneOntologyBiologicalProcess | female meiosis chromosome segregation | 6.14e-04 | 8 | 98 | 2 | GO:0016321 | |
| GeneOntologyBiologicalProcess | response to interleukin-9 | 6.14e-04 | 8 | 98 | 2 | GO:0071104 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | 6.25e-04 | 219 | 98 | 6 | GO:1901991 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | CDC14C MYBBP1A CENPE CENPF TOM1L1 SMC2 TTK CDC14B USP44 CDK5RAP2 CEP295 EXOC7 | 6.61e-04 | 845 | 98 | 12 | GO:0010564 |
| GeneOntologyBiologicalProcess | lipoprotein metabolic process | 6.85e-04 | 147 | 98 | 5 | GO:0042157 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 7.19e-04 | 407 | 98 | 8 | GO:0045787 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 7.51e-04 | 150 | 98 | 5 | GO:0002708 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 7.78e-04 | 38 | 98 | 3 | GO:0001779 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-4 | 7.78e-04 | 38 | 98 | 3 | GO:0071353 | |
| GeneOntologyBiologicalProcess | ventricular system development | 7.78e-04 | 38 | 98 | 3 | GO:0021591 | |
| GeneOntologyBiologicalProcess | taurine metabolic process | 7.87e-04 | 9 | 98 | 2 | GO:0019530 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-2 | 7.87e-04 | 9 | 98 | 2 | GO:0071352 | |
| GeneOntologyBiologicalProcess | alkanesulfonate metabolic process | 7.87e-04 | 9 | 98 | 2 | GO:0019694 | |
| GeneOntologyBiologicalProcess | interleukin-2-mediated signaling pathway | 7.87e-04 | 9 | 98 | 2 | GO:0038110 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | TBC1D30 CENPE CENPF TRPC5 TOM1L1 ARHGEF18 TTK USP44 TBC1D4 VILL XRN1 CDK5RAP2 | 8.03e-04 | 864 | 98 | 12 | GO:0051129 |
| GeneOntologyBiologicalProcess | motile cilium assembly | 8.23e-04 | 88 | 98 | 4 | GO:0044458 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 8.44e-04 | 232 | 98 | 6 | GO:0002706 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 9.81e-04 | 10 | 98 | 2 | GO:0060397 | |
| GeneOntologyBiologicalProcess | interleukin-4-mediated signaling pathway | 9.81e-04 | 10 | 98 | 2 | GO:0035771 | |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 9.81e-04 | 10 | 98 | 2 | GO:0046543 | |
| GeneOntologyBiologicalProcess | regulation of isotype switching | 1.04e-03 | 42 | 98 | 3 | GO:0045191 | |
| GeneOntologyBiologicalProcess | immune system development | 1.19e-03 | 248 | 98 | 6 | GO:0002520 | |
| GeneOntologyCellularComponent | sperm head-tail coupling apparatus | 1.43e-06 | 18 | 100 | 4 | GO:0120212 | |
| GeneOntologyCellularComponent | condensed chromosome | 1.67e-05 | 307 | 100 | 9 | GO:0000793 | |
| GeneOntologyCellularComponent | mitotic spindle | 5.15e-05 | 201 | 100 | 7 | GO:0072686 | |
| GeneOntologyCellularComponent | spindle | CDC14C CENPE CENPF TTK CDC14B USP44 RIF1 ZZZ3 CDK5RAP2 CEP295 | 8.68e-05 | 471 | 100 | 10 | GO:0005819 |
| GeneOntologyCellularComponent | platelet dense granule membrane | 3.36e-04 | 6 | 100 | 2 | GO:0031088 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 7.98e-04 | 9 | 100 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 9.58e-04 | 91 | 100 | 4 | GO:0000794 | |
| GeneOntologyCellularComponent | cAMP-dependent protein kinase complex | 9.94e-04 | 10 | 100 | 2 | GO:0005952 | |
| GeneOntologyCellularComponent | cilium | CFAP47 ABCC4 RPGRIP1L TBC1D30 CENPF CRB1 AKAP4 CFAP221 KIF19 VPS13A PRKAR1A CC2D2A | 1.19e-03 | 898 | 100 | 12 | GO:0005929 |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.21e-03 | 11 | 100 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | synaptonemal complex | 1.39e-03 | 46 | 100 | 3 | GO:0000795 | |
| GeneOntologyCellularComponent | synaptonemal structure | 1.39e-03 | 46 | 100 | 3 | GO:0099086 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.40e-03 | 254 | 100 | 6 | GO:0000228 | |
| GeneOntologyCellularComponent | microtubule organizing center | CDC14C RPGRIP1L TBC1D30 CENPF CNTLN CDC14B USO1 PRKAR1A CDK5RAP2 CEP295 EXOC7 PLEKHA7 | 1.45e-03 | 919 | 100 | 12 | GO:0005815 |
| Domain | InsP3_rcpt-bd | 8.48e-05 | 3 | 100 | 2 | IPR000493 | |
| Domain | VPS13 | 8.48e-05 | 3 | 100 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 8.48e-05 | 3 | 100 | 2 | PF16910 | |
| Domain | VPS13 | 8.48e-05 | 3 | 100 | 2 | PF16908 | |
| Domain | VPS13_N2 | 8.48e-05 | 3 | 100 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 8.48e-05 | 3 | 100 | 2 | IPR031642 | |
| Domain | SHR-BD | 1.69e-04 | 4 | 100 | 2 | IPR009543 | |
| Domain | VPS13_C | 1.69e-04 | 4 | 100 | 2 | PF16909 | |
| Domain | VPS13_C | 1.69e-04 | 4 | 100 | 2 | IPR031645 | |
| Domain | SHR-BD | 1.69e-04 | 4 | 100 | 2 | PF06650 | |
| Domain | SMC | 2.81e-04 | 5 | 100 | 2 | IPR024704 | |
| Domain | Autophagy-rel_C | 2.81e-04 | 5 | 100 | 2 | IPR015412 | |
| Domain | ATG_C | 2.81e-04 | 5 | 100 | 2 | PF09333 | |
| Domain | RIH_assoc-dom | 4.20e-04 | 6 | 100 | 2 | IPR013662 | |
| Domain | SMC_hinge | 4.20e-04 | 6 | 100 | 2 | SM00968 | |
| Domain | Ins145_P3_rec | 4.20e-04 | 6 | 100 | 2 | PF08709 | |
| Domain | RIH_assoc | 4.20e-04 | 6 | 100 | 2 | PF08454 | |
| Domain | RIH_dom | 4.20e-04 | 6 | 100 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.20e-04 | 6 | 100 | 2 | IPR014821 | |
| Domain | SMC_hinge | 4.20e-04 | 6 | 100 | 2 | PF06470 | |
| Domain | Ryanodine_recept-rel | 4.20e-04 | 6 | 100 | 2 | IPR015925 | |
| Domain | - | 4.20e-04 | 6 | 100 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.20e-04 | 6 | 100 | 2 | PF01365 | |
| Domain | SMC_hinge | 4.20e-04 | 6 | 100 | 2 | IPR010935 | |
| Domain | STAT_TF_DNA-bd_sub | 5.86e-04 | 7 | 100 | 2 | IPR012345 | |
| Domain | STAT | 5.86e-04 | 7 | 100 | 2 | IPR001217 | |
| Domain | STAT_int | 5.86e-04 | 7 | 100 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 5.86e-04 | 7 | 100 | 2 | IPR013801 | |
| Domain | STAT_bind | 5.86e-04 | 7 | 100 | 2 | PF02864 | |
| Domain | STAT_int | 5.86e-04 | 7 | 100 | 2 | PF02865 | |
| Domain | - | 5.86e-04 | 7 | 100 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 5.86e-04 | 7 | 100 | 2 | PF01017 | |
| Domain | - | 5.86e-04 | 7 | 100 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 5.86e-04 | 7 | 100 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 5.86e-04 | 7 | 100 | 2 | IPR015988 | |
| Domain | - | 5.86e-04 | 7 | 100 | 2 | 2.60.40.630 | |
| Domain | STAT_TF_alpha | 7.78e-04 | 8 | 100 | 2 | IPR013800 | |
| Domain | Chorein_N | 7.78e-04 | 8 | 100 | 2 | PF12624 | |
| Domain | VPS13_N | 7.78e-04 | 8 | 100 | 2 | IPR026854 | |
| Domain | RecF/RecN/SMC_N | 7.78e-04 | 8 | 100 | 2 | IPR003395 | |
| Domain | SMC_N | 7.78e-04 | 8 | 100 | 2 | PF02463 | |
| Domain | MIR | 1.24e-03 | 10 | 100 | 2 | PF02815 | |
| Domain | MIR_motif | 1.24e-03 | 10 | 100 | 2 | IPR016093 | |
| Domain | MIR | 1.24e-03 | 10 | 100 | 2 | PS50919 | |
| Domain | MIR | 1.24e-03 | 10 | 100 | 2 | SM00472 | |
| Domain | Kinesin_motor_CS | 1.37e-03 | 41 | 100 | 3 | IPR019821 | |
| Domain | Kinesin-like_fam | 1.57e-03 | 43 | 100 | 3 | IPR027640 | |
| Domain | - | 1.68e-03 | 44 | 100 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 1.68e-03 | 44 | 100 | 3 | PF00225 | |
| Domain | KISc | 1.68e-03 | 44 | 100 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.68e-03 | 44 | 100 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.68e-03 | 44 | 100 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.68e-03 | 44 | 100 | 3 | PS50067 | |
| Domain | ARM-type_fold | 2.31e-03 | 339 | 100 | 7 | IPR016024 | |
| Domain | ABC_transporter-like | 2.43e-03 | 50 | 100 | 3 | IPR003439 | |
| Domain | p53-like_TF_DNA-bd | 2.87e-03 | 53 | 100 | 3 | IPR008967 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 2.64e-06 | 6 | 73 | 3 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 2.64e-06 | 6 | 73 | 3 | MM15621 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 4.59e-06 | 7 | 73 | 3 | M47581 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.09e-05 | 9 | 73 | 3 | M27861 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.56e-05 | 10 | 73 | 3 | M27898 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.56e-05 | 10 | 73 | 3 | MM15618 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 2.13e-05 | 11 | 73 | 3 | MM15578 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 2.83e-05 | 12 | 73 | 3 | M27893 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 4.65e-05 | 14 | 73 | 3 | M27858 | |
| Pathway | WP_FOXP3_IN_COVID19 | 5.80e-05 | 15 | 73 | 3 | M42573 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 5.80e-05 | 15 | 73 | 3 | MM14536 | |
| Pathway | WP_IL9_SIGNALING | 8.60e-05 | 17 | 73 | 3 | M39644 | |
| Pathway | WP_FOXA2_PATHWAY | 1.66e-04 | 21 | 73 | 3 | M42579 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 1.91e-04 | 22 | 73 | 3 | M7747 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 2.19e-04 | 23 | 73 | 3 | MM1411 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 2.19e-04 | 23 | 73 | 3 | M47904 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 2.62e-04 | 5 | 73 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 2.62e-04 | 5 | 73 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 2.62e-04 | 5 | 73 | 2 | M49006 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 2.62e-04 | 5 | 73 | 2 | M49000 | |
| Pathway | WP_IL7_SIGNALING | 2.82e-04 | 25 | 73 | 3 | M39499 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 3.56e-04 | 27 | 73 | 3 | M12123 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 3.91e-04 | 6 | 73 | 2 | M47960 | |
| Pathway | PID_IL2_STAT5_PATHWAY | 4.89e-04 | 30 | 73 | 3 | M234 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 5.46e-04 | 7 | 73 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 5.46e-04 | 7 | 73 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 5.46e-04 | 7 | 73 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 5.46e-04 | 7 | 73 | 2 | M27907 | |
| Pathway | REACTOME_HEMOSTASIS | KIF21B ABCC4 ANGPT2 CENPE APOB ITPR1 ITPR2 KIF19 PRKAR1A RASGRP2 | 6.85e-04 | 571 | 73 | 10 | MM14472 |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 7.74e-04 | 35 | 73 | 3 | MM15144 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 8.41e-04 | 36 | 73 | 3 | M542 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 8.41e-04 | 36 | 73 | 3 | MM1418 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 9.12e-04 | 37 | 73 | 3 | M8615 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS | 9.30e-04 | 9 | 73 | 2 | M29789 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 9.30e-04 | 9 | 73 | 2 | M47852 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 9.30e-04 | 9 | 73 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 9.30e-04 | 9 | 73 | 2 | M8066 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.16e-03 | 10 | 73 | 2 | M47661 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 1.16e-03 | 10 | 73 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 1.23e-03 | 41 | 73 | 3 | MM15162 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.23e-03 | 41 | 73 | 3 | M512 | |
| Pathway | WP_IL2_SIGNALING | 1.32e-03 | 42 | 73 | 3 | M39536 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.32e-03 | 42 | 73 | 3 | M791 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 1.41e-03 | 11 | 73 | 2 | M27195 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.41e-03 | 11 | 73 | 2 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.41e-03 | 11 | 73 | 2 | M27466 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 1.42e-03 | 43 | 73 | 3 | MM15864 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 1.52e-03 | 44 | 73 | 3 | M1012 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 1.62e-03 | 45 | 73 | 3 | M47408 | |
| Pathway | WP_ELONGATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS | 1.69e-03 | 12 | 73 | 2 | MM17077 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 1.95e-03 | 48 | 73 | 3 | M914 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.99e-03 | 13 | 73 | 2 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.99e-03 | 13 | 73 | 2 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.99e-03 | 13 | 73 | 2 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.99e-03 | 13 | 73 | 2 | MM14553 | |
| Pathway | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | 2.07e-03 | 49 | 73 | 3 | M92 | |
| Pathway | PID_IL5_PATHWAY | 2.31e-03 | 14 | 73 | 2 | M135 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.36e-03 | 108 | 73 | 4 | M17034 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 2.45e-03 | 52 | 73 | 3 | M2404 | |
| Pathway | REACTOME_HEMOSTASIS | KIF21B ABCC4 ANGPT2 CENPE APOB ITPR1 ITPR2 KIF19 PRKAR1A RASGRP2 | 2.51e-03 | 679 | 73 | 10 | M8395 |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 2.66e-03 | 15 | 73 | 2 | M552 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 2.66e-03 | 15 | 73 | 2 | MM1412 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 2.66e-03 | 15 | 73 | 2 | M17681 | |
| Pathway | WP_IL4_SIGNALING | 2.73e-03 | 54 | 73 | 3 | M39720 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.73e-03 | 54 | 73 | 3 | M26911 | |
| Pathway | PID_IL2_1PATHWAY | 2.88e-03 | 55 | 73 | 3 | M122 | |
| Pathway | REACTOME_CELL_CYCLE | CENPE CENPF SMC2 SYCP2 USO1 PRIM1 MLH1 CDK5RAP2 ANAPC16 SMC1B | 2.94e-03 | 694 | 73 | 10 | M543 |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 3.03e-03 | 16 | 73 | 2 | MM15710 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 3.03e-03 | 16 | 73 | 2 | M26945 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.03e-03 | 16 | 73 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.03e-03 | 16 | 73 | 2 | MM1420 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 3.03e-03 | 16 | 73 | 2 | M41733 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 3.06e-03 | 116 | 73 | 4 | MM15715 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | MON2 CDC14C MYBBP1A CENPE RB1CC1 CDC14B ITPR1 DST NF2 VILL CDK5RAP2 ANAPC16 | 8.12e-10 | 363 | 102 | 12 | 14691545 |
| Pubmed | CENPF RB1CC1 ZBTB1 FASN ZZZ3 TBC1D4 DST USO1 TBK1 XRN1 PLEKHA5 CNOT1 | 3.96e-09 | 418 | 102 | 12 | 34709266 | |
| Pubmed | CCDC134 ABCC4 MYBBP1A CENPE TTK ITPR1 ITPR2 FASN NF2 USO1 PRIM1 XRN1 MLH1 PRKAR1A PLEKHA5 EXOC7 IL2RG CNOT1 | 8.18e-09 | 1168 | 102 | 18 | 19946888 | |
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 12496402 | ||
| Pubmed | PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis. | 2.45e-08 | 3 | 102 | 3 | 24263804 | |
| Pubmed | MON2 RPGRIP1L CENPE VPS13C ARHGEF18 CHD1 ITPR2 USO1 XRN1 PLEKHA5 ANAPC16 DCLRE1A CEP295 EXOC7 | 3.25e-08 | 733 | 102 | 14 | 34672954 | |
| Pubmed | MYBBP1A RPGRIP1L VPS13C APOB CRB1 SH3BP4 RIF1 DST NF2 USO1 VPS13A XRN1 CDK5RAP2 DCLRE1A | 6.66e-08 | 777 | 102 | 14 | 35844135 | |
| Pubmed | MON2 MYBBP1A RPGRIP1L RB1CC1 CDC14B ITPR1 ITPR2 RIF1 TBC1D4 NF2 PRIM1 VPS13A MLH1 CDK5RAP2 PLEKHA7 CNOT1 | 7.00e-08 | 1049 | 102 | 16 | 27880917 | |
| Pubmed | Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis. | 9.78e-08 | 4 | 102 | 3 | 26338970 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 14726409 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 30679796 | ||
| Pubmed | KIF21B MYBBP1A UACA CENPE CENPF ARHGEF18 SMC2 ZBTB1 DST TBK1 PRKAR1A CDK5RAP2 PLEKHA5 DNM1 CNOT1 | 1.43e-07 | 963 | 102 | 15 | 28671696 | |
| Pubmed | Stat5a/b are essential for normal lymphoid development and differentiation. | 2.44e-07 | 5 | 102 | 3 | 16418296 | |
| Pubmed | 2.44e-07 | 5 | 102 | 3 | 26603207 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 TBC1D30 CENPE CENPF VPS13C ITPR2 ZZZ3 TBC1D4 DST TBK1 VPS13A CEP295 CNOT1 | 2.55e-07 | 736 | 102 | 13 | 29676528 |
| Pubmed | SMC2 STAT5B ITPR1 SH3BP4 DST TBK1 XRN1 SIK2 MLH1 PLEKHA5 DNM1 EXOC7 | 4.80e-07 | 650 | 102 | 12 | 38777146 | |
| Pubmed | Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation. | 4.87e-07 | 6 | 102 | 3 | 19923221 | |
| Pubmed | 5.88e-07 | 102 | 102 | 6 | 10231032 | ||
| Pubmed | Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in mice. | 8.50e-07 | 7 | 102 | 3 | 27858140 | |
| Pubmed | ABCC4 UACA CENPE ZSWIM5 TOM1L1 CHD1 ZBTB1 ITPR1 NF2 ARIH2 VPS13A MLH1 MAP3K15 PLEKHA7 TLCD3A | 2.62e-06 | 1215 | 102 | 15 | 15146197 | |
| Pubmed | 2.90e-06 | 10 | 102 | 3 | 17182565 | ||
| Pubmed | 5.29e-06 | 12 | 102 | 3 | 37550517 | ||
| Pubmed | Divergent Role for STAT5 in the Adaptive Responses of Natural Killer Cells. | 5.29e-06 | 12 | 102 | 3 | 33326784 | |
| Pubmed | 5.79e-06 | 151 | 102 | 6 | 17043677 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 6.61e-06 | 565 | 102 | 10 | 25468996 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDS1 ABCC4 UACA VPS13C TOM1L1 ARHGEF18 CDC14B STAT5B SH3BP4 ZNF331 FOXP4 TBC1D4 NF2 TBK1 DHRSX CNOT1 | 6.90e-06 | 1489 | 102 | 16 | 28611215 |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23151802 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 26999798 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 8.52e-06 | 2 | 102 | 2 | 31443474 | |
| Pubmed | NF2 regulates IP3R-mediated Ca2+ signal and apoptosis in meningiomas. | 8.52e-06 | 2 | 102 | 2 | 38953724 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12377952 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19923902 | ||
| Pubmed | The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway. | 8.52e-06 | 2 | 102 | 2 | 21502810 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12896975 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 8.52e-06 | 2 | 102 | 2 | 21127177 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16289657 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25552366 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 8.52e-06 | 2 | 102 | 2 | 21431790 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28500076 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 21826656 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 7720707 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 8.52e-06 | 2 | 102 | 2 | 27264955 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22159083 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15201137 | ||
| Pubmed | Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein. | 8.52e-06 | 2 | 102 | 2 | 18547142 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20008792 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 33199496 | ||
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 8.52e-06 | 2 | 102 | 2 | 23582047 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16502315 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12217382 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 31599926 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 10594041 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 21036145 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 10486277 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 8.52e-06 | 2 | 102 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 8.52e-06 | 2 | 102 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 8.52e-06 | 2 | 102 | 2 | 30377054 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 8.52e-06 | 2 | 102 | 2 | 32790723 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18492722 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 10066807 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 10835485 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 35464049 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 8.52e-06 | 2 | 102 | 2 | 23773921 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 8.52e-06 | 2 | 102 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 8.52e-06 | 2 | 102 | 2 | 24878107 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12847485 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12835478 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 8.52e-06 | 2 | 102 | 2 | 24497979 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 8.52e-06 | 2 | 102 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 8.52e-06 | 2 | 102 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 8.52e-06 | 2 | 102 | 2 | 10486314 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 8.52e-06 | 2 | 102 | 2 | 24497923 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 24335105 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 8.52e-06 | 2 | 102 | 2 | 29460051 | |
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 8.52e-06 | 2 | 102 | 2 | 19120126 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28606561 | ||
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 8.52e-06 | 2 | 102 | 2 | 12393407 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12039059 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 21178171 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 8.52e-06 | 2 | 102 | 2 | 20233708 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 8.52e-06 | 2 | 102 | 2 | 16775227 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17447893 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 33674626 | ||
| Pubmed | Identification of the proteoglycan binding site in apolipoprotein B48. | 8.52e-06 | 2 | 102 | 2 | 12070165 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16115927 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23275557 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11867689 | ||
| Pubmed | Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | 8.52e-06 | 2 | 102 | 2 | 15980098 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15340066 | ||
| Pubmed | Brain-specific transcript variants of 5' and 3' ends of mouse VPS13A and VPS13C. | 8.52e-06 | 2 | 102 | 2 | 17196930 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18708078 | ||
| Pubmed | STAT5A/B gene locus undergoes amplification during human prostate cancer progression. | 8.52e-06 | 2 | 102 | 2 | 23660011 | |
| Pubmed | Role of Stat5 in type I interferon-signaling and transcriptional regulation. | 8.52e-06 | 2 | 102 | 2 | 12901872 | |
| Interaction | KDM1A interactions | RPGRIP1L CENPF MTF2 RB1CC1 ZBTB1 TUFT1 FASN ZZZ3 TBC1D4 DST NF2 USO1 TBK1 XRN1 PLEKHA5 EXOC7 CNOT1 TBX5 | 1.05e-06 | 941 | 102 | 18 | int:KDM1A |
| Interaction | PHF21A interactions | CENPF RB1CC1 ZBTB1 TUFT1 ZZZ3 TBC1D4 DST USO1 TBK1 XRN1 PLEKHA5 | 1.33e-06 | 343 | 102 | 11 | int:PHF21A |
| Interaction | NINL interactions | RPGRIP1L CENPE CNTLN SMC2 TTK TBC1D4 TBK1 XRN1 CC2D2A CEP295 PLEKHA7 CNOT1 | 3.49e-06 | 458 | 102 | 12 | int:NINL |
| Interaction | CEP152 interactions | 3.57e-06 | 179 | 102 | 8 | int:CEP152 | |
| Interaction | SCN2B interactions | 8.75e-06 | 95 | 102 | 6 | int:SCN2B | |
| Interaction | FGFR1 interactions | MON2 UACA TRAPPC8 SMC2 TTK CTPS2 NF2 USO1 PRKAR1A SHE PLEKHA5 PLEKHA7 IL27RA | 1.81e-05 | 632 | 102 | 13 | int:FGFR1 |
| Interaction | NDC80 interactions | 2.96e-05 | 312 | 102 | 9 | int:NDC80 | |
| Interaction | YWHAH interactions | KIF21B RPGRIP1L UACA RB1CC1 TTK SH3BP4 PYHIN1 TBC1D4 DST TBK1 XRN1 SIK2 CC2D2A PLEKHA5 DCLRE1A MAP3K15 PLEKHA7 | 3.62e-05 | 1102 | 102 | 17 | int:YWHAH |
| Interaction | HDAC1 interactions | MYBBP1A CENPF CHD1 RB1CC1 SMC2 ZBTB1 STAT5A FASN ZZZ3 TBC1D4 DST NF2 USO1 TBK1 XRN1 CDK5RAP2 PLEKHA5 | 3.87e-05 | 1108 | 102 | 17 | int:HDAC1 |
| Interaction | GJA1 interactions | MON2 UACA APOB TRAPPC8 SH3BP4 ITPR2 DST NF2 USO1 VPS13A PLEKHA5 PLEKHA7 | 3.87e-05 | 583 | 102 | 12 | int:GJA1 |
| Interaction | RCOR1 interactions | CENPF RB1CC1 SMC2 ZBTB1 TUFT1 FASN ZZZ3 DST XRN1 PLEKHA5 TBX5 | 4.10e-05 | 494 | 102 | 11 | int:RCOR1 |
| Interaction | SLC39A9 interactions | 6.70e-05 | 136 | 102 | 6 | int:SLC39A9 | |
| Interaction | CEP135 interactions | 7.29e-05 | 272 | 102 | 8 | int:CEP135 | |
| Interaction | SYNE3 interactions | CCDC134 CENPE VPS13C TTK DST TBK1 CDK5RAP2 CEP295 PLEKHA7 CNOT1 | 8.51e-05 | 444 | 102 | 10 | int:SYNE3 |
| Interaction | YWHAZ interactions | CCDC134 RPGRIP1L UACA ARHGEF18 RB1CC1 NEB SMC2 TRIM59 ITPR1 SH3BP4 TBC1D4 DST SIK2 PRKAR1A CDK5RAP2 PLEKHA5 MAP3K15 PLEKHA7 | 1.02e-04 | 1319 | 102 | 18 | int:YWHAZ |
| Interaction | KCNA3 interactions | MYBBP1A SMC2 TTK FASN TBC1D4 DST NF2 USO1 VPS13A XRN1 CDK5RAP2 PLEKHA5 DNM1 CNOT1 | 1.24e-04 | 871 | 102 | 14 | int:KCNA3 |
| Interaction | MIB1 interactions | 1.28e-04 | 295 | 102 | 8 | int:MIB1 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 3.35e-05 | 3 | 61 | 2 | 297 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 2.33e-04 | 7 | 61 | 2 | 761 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.60e-04 | 181 | 61 | 5 | 694 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 5.00e-04 | 46 | 61 | 3 | 622 | |
| GeneFamily | Fibrinogen C domain containing | 3.20e-03 | 25 | 61 | 2 | 554 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 4.29e-03 | 29 | 61 | 2 | 396 | |
| GeneFamily | SH2 domain containing | 4.82e-03 | 101 | 61 | 3 | 741 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.15e-03 | 206 | 61 | 4 | 682 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KIF21B VPS13C CHD1 RB1CC1 TRAPPC8 ZBTB1 STAT5A STAT5B ITPR1 ITPR2 PYHIN1 RIF1 TBC1D4 TBK1 UGP2 XRN1 PRKAR1A ANAPC16 IL2RG CNOT1 IL27RA RASGRP2 | 5.24e-08 | 1492 | 102 | 22 | M40023 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | CENPE CENPF MTF2 HMGXB4 SMC2 TTK STAT5A RIF1 SYCP2 PRIM1 VPS13A MLH1 | 1.05e-07 | 426 | 102 | 12 | M9516 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CENPE LYPLAL1 VPS13C CHD1 RB1CC1 TRAPPC8 SMC2 TTK ITPR1 ITPR2 RIF1 ZZZ3 TBK1 CDK5RAP2 | 2.58e-07 | 656 | 102 | 14 | M18979 |
| Coexpression | FISCHER_DREAM_TARGETS | UACA CENPE CENPF MTF2 HMGXB4 SMC2 TTK TRIM59 RIF1 NF2 PRIM1 CDK5RAP2 DCLRE1A CEP295 CNOT1 | 5.12e-06 | 969 | 102 | 15 | M149 |
| Coexpression | MISSIAGLIA_REGULATED_BY_METHYLATION_DN | 8.40e-06 | 122 | 102 | 6 | M6866 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | RPGRIP1L UACA CENPE CENPF VPS13C SMC2 TTK TRIM59 SH3BP4 CTPS2 DST PRIM1 PRKAR1A CEP295 | 9.33e-06 | 892 | 102 | 14 | M18120 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPE CENPF MTF2 HMGXB4 CHD1 RB1CC1 TRAPPC8 TTK ITPR1 RIF1 ZZZ3 DST VPS13A | 2.81e-05 | 856 | 102 | 13 | M4500 |
| Coexpression | ZHONG_PFC_C1_OPC | 4.14e-05 | 238 | 102 | 7 | M39096 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 6.65e-05 | 176 | 102 | 6 | M2981 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.53e-05 | 180 | 102 | 6 | M8239 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | 7.65e-05 | 458 | 102 | 9 | M8520 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | CENPE CENPF HMGXB4 CNTLN SMC2 TTK RIF1 PRIM1 MLH1 CDK5RAP2 CEP295 | 8.31e-05 | 694 | 102 | 11 | M45767 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 8.73e-05 | 466 | 102 | 9 | M13522 | |
| Coexpression | REN_BOUND_BY_E2F | 1.01e-04 | 62 | 102 | 4 | M4493 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 1.06e-04 | 478 | 102 | 9 | M45785 | |
| Coexpression | VEGF_A_UP.V1_DN | 1.10e-04 | 193 | 102 | 6 | M2675 | |
| Coexpression | DESCARTES_FETAL_HEART_ERYTHROBLASTS | 1.22e-04 | 283 | 102 | 7 | M40202 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH1_DN | 1.27e-04 | 198 | 102 | 6 | M5454 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 1.31e-04 | 199 | 102 | 6 | M6264 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_LYMPHOID_CELLS | 1.31e-04 | 125 | 102 | 5 | M40260 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP | 1.34e-04 | 200 | 102 | 6 | M4604 | |
| Coexpression | GSE14308_INDUCED_VS_NATURAL_TREG_DN | 1.34e-04 | 200 | 102 | 6 | M3399 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN | 1.34e-04 | 200 | 102 | 6 | M9302 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.75e-04 | 300 | 102 | 7 | M8702 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 1.78e-04 | 402 | 102 | 8 | MM454 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 1.94e-04 | 305 | 102 | 7 | M19875 | |
| Coexpression | MCCLUNG_COCAIN_REWARD_4WK | 2.02e-04 | 74 | 102 | 4 | M1600 | |
| Coexpression | ODONNELL_TFRC_TARGETS_DN | 2.15e-04 | 139 | 102 | 5 | M6451 | |
| Coexpression | MCCLUNG_COCAIN_REWARD_4WK | 2.24e-04 | 76 | 102 | 4 | MM682 | |
| Coexpression | ZHONG_PFC_C2_UNKNOWN_NPC | 2.24e-04 | 76 | 102 | 4 | M39087 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-07 | 167 | 102 | 7 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-07 | 175 | 102 | 7 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.82e-07 | 190 | 102 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 2.92e-07 | 191 | 102 | 7 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.92e-07 | 191 | 102 | 7 | f764cc21fef87ebad765011098f647ae1bdf6158 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.73e-07 | 198 | 102 | 7 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.73e-07 | 198 | 102 | 7 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.86e-07 | 199 | 102 | 7 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-06 | 167 | 102 | 6 | d21635df8b74189e3309eaf435af381fbe412574 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-06 | 172 | 102 | 6 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-06 | 174 | 102 | 6 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-06 | 174 | 102 | 6 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-06 | 175 | 102 | 6 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-06 | 176 | 102 | 6 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-06 | 176 | 102 | 6 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.25e-06 | 176 | 102 | 6 | 8385435074cc5235b7af7424974f609388fc2cff | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.35e-06 | 177 | 102 | 6 | ba701d3c90722d8bff70d0fa651899305cdad257 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-06 | 179 | 102 | 6 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-06 | 180 | 102 | 6 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.81e-06 | 181 | 102 | 6 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.81e-06 | 181 | 102 | 6 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 4.33e-06 | 185 | 102 | 6 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 186 | 102 | 6 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 186 | 102 | 6 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 4.74e-06 | 188 | 102 | 6 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 4.74e-06 | 188 | 102 | 6 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 4.89e-06 | 189 | 102 | 6 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.89e-06 | 189 | 102 | 6 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.04e-06 | 190 | 102 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 5.19e-06 | 191 | 102 | 6 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-06 | 191 | 102 | 6 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.35e-06 | 192 | 102 | 6 | 5ef79faddb433c09ff36660d8bf7a3af5a67bf1d | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.51e-06 | 193 | 102 | 6 | 1e95ef29357969ee385b4717c0b5a497390ac260 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.51e-06 | 193 | 102 | 6 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.51e-06 | 193 | 102 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.51e-06 | 193 | 102 | 6 | 0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.68e-06 | 194 | 102 | 6 | d840c1949c328779426c9172e02da09e968f0567 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.68e-06 | 194 | 102 | 6 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.85e-06 | 195 | 102 | 6 | be8db0a22ef8ce24819f790b0bd93670e73af76f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 5.85e-06 | 195 | 102 | 6 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.85e-06 | 195 | 102 | 6 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.02e-06 | 196 | 102 | 6 | 76f581e35967f8f7c85a8556129f6e8042ad11ca | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-06 | 196 | 102 | 6 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-06 | 196 | 102 | 6 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.20e-06 | 197 | 102 | 6 | a41420d4b6d502c2f594c054c7efbb5d4eac83ff | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.20e-06 | 197 | 102 | 6 | 29b0a5927f80455eef7b793feabef69fba1a3df1 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 197 | 102 | 6 | 9b2c67de46bd59bf56c81a0d10b84cf4a041c120 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.20e-06 | 197 | 102 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 197 | 102 | 6 | f84f0ddf51208764ab56408d97035bbff562e59d | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.20e-06 | 197 | 102 | 6 | 1c89d6836eed30c50c765f7dde9cc8ee15c363d2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.38e-06 | 198 | 102 | 6 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.38e-06 | 198 | 102 | 6 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.38e-06 | 198 | 102 | 6 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.38e-06 | 198 | 102 | 6 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.57e-06 | 199 | 102 | 6 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 6.57e-06 | 199 | 102 | 6 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.76e-06 | 200 | 102 | 6 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 6.76e-06 | 200 | 102 | 6 | c88d8e67647c90d1fa2569516865a9fd766eaf1c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.76e-06 | 200 | 102 | 6 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.76e-06 | 200 | 102 | 6 | 762442d125e594fede4506b72da15563b1d8798a | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.76e-06 | 200 | 102 | 6 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-06 | 200 | 102 | 6 | e269a61858ac610e914b684d9a3c084e9600fb1c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 6.76e-06 | 200 | 102 | 6 | 28935053cd6918cd2e9f3e7691f8522216585cb6 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-17|World / Primary Cells by Cluster | 6.76e-06 | 200 | 102 | 6 | 4417f14d45ce683c1a45ec989ae63ee6c047353e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-06 | 200 | 102 | 6 | 6145bdee0d9954da7b096be4fe797066a6df2bd0 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-06 | 200 | 102 | 6 | f95769e24763900eac317c6f8adbf064bae9feaf | |
| ToppCell | Endothelial-H_(cycle)|World / shred on cell class and cell subclass (v4) | 1.39e-05 | 133 | 102 | 5 | 8e3005114761feee028c496cc739e607b35d7831 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-05 | 156 | 102 | 5 | 7ccd20e3bbce6a070df45034b0bdc255f267efb1 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.08e-05 | 157 | 102 | 5 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 159 | 102 | 5 | a5509f0604ef0caef5ed1af83dd89c86686c73cc | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-05 | 163 | 102 | 5 | 7864e966c228282b4b63c43164dba3faba21026d | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.79e-05 | 164 | 102 | 5 | 249d8f75a64bce7db52ce0c563f496b9edf602a6 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lung / Location, Cell class and cell subclass | 4.02e-05 | 166 | 102 | 5 | ff32422390852546e0cb216192452e9c47bd9509 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.37e-05 | 169 | 102 | 5 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-05 | 169 | 102 | 5 | a3234904d7ff8f451ca894e93badd61d75e3cd2a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 169 | 102 | 5 | d721dbb317a88113b4f76688111908d00f23e899 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.50e-05 | 170 | 102 | 5 | b04e2f84024baaae9b4ff19bdac8c69afdb92a76 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.50e-05 | 170 | 102 | 5 | 6b91d4cbe0697b65bfb2e099e7a9b39ea2fba3a9 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 4.63e-05 | 171 | 102 | 5 | 976361f67dd725870e0513ae7a92f2dcaee17148 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-05 | 171 | 102 | 5 | 6e7ade1d14a3ec4c566476aac3eb509bd2661e39 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-05 | 171 | 102 | 5 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.63e-05 | 171 | 102 | 5 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-05 | 171 | 102 | 5 | 285533ca2a6a411773313166bee35542f34d1a3c | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-05 | 171 | 102 | 5 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 4.76e-05 | 172 | 102 | 5 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-05 | 172 | 102 | 5 | 4bdcf1ae2a1cfba0272c54072e37fb7958904321 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.76e-05 | 172 | 102 | 5 | b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 172 | 102 | 5 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-GABAergic_neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.02e-05 | 88 | 102 | 4 | 5582fd7bac60c690ecd1f2aff1d446ccb69f79b9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 174 | 102 | 5 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 174 | 102 | 5 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 5.02e-05 | 174 | 102 | 5 | e4c8da80eca07e4396f57dad212f76c2eca4c1bd | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 175 | 102 | 5 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 175 | 102 | 5 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.16e-05 | 175 | 102 | 5 | 16c835e62a3321f6cf6163954889946bbb869498 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.30e-05 | 176 | 102 | 5 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 176 | 102 | 5 | acd05ca8952710feedbfe377b1330f3c2406d044 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.30e-05 | 176 | 102 | 5 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.30e-05 | 176 | 102 | 5 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 5.45e-05 | 177 | 102 | 5 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| Computational | Neighborhood of SMC2L1 | 1.23e-06 | 33 | 63 | 5 | GNF2_SMC2L1 | |
| Computational | Neighborhood of RFC4 | 2.51e-05 | 60 | 63 | 5 | GNF2_RFC4 | |
| Computational | Neighborhood of CENPF | 2.95e-05 | 62 | 63 | 5 | GNF2_CENPF | |
| Computational | Neighborhood of CDC2 | 2.95e-05 | 62 | 63 | 5 | GNF2_CDC2 | |
| Computational | Neighborhood of CCNA2 | 4.62e-05 | 68 | 63 | 5 | GNF2_CCNA2 | |
| Computational | Neighborhood of PCNA | 4.62e-05 | 68 | 63 | 5 | GNF2_PCNA | |
| Computational | Neighborhood of CENPE | 9.22e-05 | 41 | 63 | 4 | GNF2_CENPE | |
| Computational | Spindle and kinetochore. | 1.02e-04 | 16 | 63 | 3 | MODULE_315 | |
| Computational | Neighborhood of HMMR | 1.58e-04 | 47 | 63 | 4 | GNF2_HMMR | |
| Computational | Neighborhood of RRM1 | 1.59e-04 | 88 | 63 | 5 | GNF2_RRM1 | |
| Computational | Neighborhood of CKS2 | 2.02e-04 | 50 | 63 | 4 | GNF2_CKS2 | |
| Computational | Cancer module 320: M phase. | 2.04e-04 | 20 | 63 | 3 | MODULE_320 | |
| Computational | Neighborhood of CDC20 | 3.13e-04 | 56 | 63 | 4 | GNF2_CDC20 | |
| Computational | Neighborhood of CCNB2 | 3.35e-04 | 57 | 63 | 4 | GNF2_CCNB2 | |
| Computational | Neighborhood of SMC4L1 | 1.46e-03 | 84 | 63 | 4 | GNF2_SMC4L1 | |
| Computational | Neighborhood of TTK | 1.51e-03 | 39 | 63 | 3 | GNF2_TTK | |
| Computational | DNA replication. | 2.00e-03 | 43 | 63 | 3 | MODULE_158 | |
| Computational | Genes in the cancer module 125. | 2.14e-03 | 44 | 63 | 3 | MODULE_125 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.32e-07 | 182 | 102 | 9 | 3887_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.52e-06 | 180 | 102 | 8 | 3688_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 2.02e-06 | 187 | 102 | 8 | 7080_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.10e-06 | 198 | 102 | 8 | 2297_DN | |
| Drug | 2,4-dihydroxy-N-(4-hydroxyphenyl)benzamide | 1.02e-05 | 10 | 102 | 3 | ctd:C585912 | |
| Drug | Organothiophosphates | 1.40e-05 | 11 | 102 | 3 | ctd:D063086 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.51e-05 | 177 | 102 | 7 | 4821_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.69e-05 | 180 | 102 | 7 | 5484_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 1.88e-05 | 183 | 102 | 7 | 5981_UP | |
| Drug | Methiazole; Up 200; 15uM; PC3; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 3796_UP | |
| Drug | Etomidate [33125-97-2]; Up 200; 16.4uM; HL60; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 2958_UP | |
| Drug | copper(II) sulfate pentahydrate; Down 200; 100uM; ssMCF7; HG-U133A | 2.91e-05 | 196 | 102 | 7 | 500_DN | |
| Drug | sulindac sulfide; Down 200; 50uM; MCF7; HG-U133A | 3.01e-05 | 197 | 102 | 7 | 308_DN | |
| Drug | Cinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 3463_UP | |
| Drug | Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 5399_UP | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 4704_DN | |
| Drug | Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 5353_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; PC3; HT_HG-U133A | 3.32e-05 | 200 | 102 | 7 | 3667_UP | |
| Drug | menthol glucuronide | 5.94e-05 | 3 | 102 | 2 | CID000133208 | |
| Disease | Prostatic Neoplasms | ABCC4 MYBBP1A PIGP CENPF TOM1L1 CHD1 ITPR1 PYHIN1 FOXP4 USO1 MLH1 | 7.93e-06 | 616 | 100 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | ABCC4 MYBBP1A PIGP CENPF TOM1L1 CHD1 ITPR1 PYHIN1 FOXP4 USO1 MLH1 | 7.93e-06 | 616 | 100 | 11 | C0376358 |
| Disease | Hypoxic Brain Damage | 1.14e-05 | 2 | 100 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 1.14e-05 | 2 | 100 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 1.14e-05 | 2 | 100 | 2 | C1527348 | |
| Disease | Anoxia of brain | 1.14e-05 | 2 | 100 | 2 | C0995195 | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 1.14e-05 | 2 | 100 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 1.14e-05 | 2 | 100 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | COACH syndrome | 3.40e-05 | 3 | 100 | 2 | cv:C1857662 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | COACH syndrome | 6.79e-05 | 4 | 100 | 2 | C1857662 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 9.28e-05 | 26 | 100 | 3 | DOID:234 (is_implicated_in) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 3.14e-04 | 8 | 100 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Meckel syndrome (implicated_via_orthology) | 3.14e-04 | 8 | 100 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | retinitis pigmentosa (is_implicated_in) | 3.67e-04 | 41 | 100 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | Meckel-Gruber syndrome | 5.03e-04 | 10 | 100 | 2 | cv:C0265215 | |
| Disease | Polydactyly | 6.87e-04 | 117 | 100 | 4 | C0152427 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 7.34e-04 | 12 | 100 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Leber congenital amaurosis (implicated_via_orthology) | 8.66e-04 | 13 | 100 | 2 | DOID:14791 (implicated_via_orthology) | |
| Disease | clonal hematopoiesis mutation measurement | 8.72e-04 | 55 | 100 | 3 | EFO_0020949 | |
| Disease | age at menarche | 9.46e-04 | 594 | 100 | 8 | EFO_0004703 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 1.01e-03 | 14 | 100 | 2 | DOID:7474 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | CDS1 CENPF ZSWIM5 RB1CC1 TRAPPC8 STAT5A BGN RIF1 FOXP4 FASN NF2 | 1.04e-03 | 1074 | 100 | 11 | C0006142 |
| Disease | Meckel-Gruber syndrome | 1.16e-03 | 15 | 100 | 2 | C0265215 | |
| Disease | Autosomal recessive primary microcephaly | 1.16e-03 | 15 | 100 | 2 | cv:C3711387 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.32e-03 | 16 | 100 | 2 | C0393706 | |
| Disease | Feeding difficulties | 1.68e-03 | 18 | 100 | 2 | C0232466 | |
| Disease | Meckel syndrome type 1 | 1.68e-03 | 18 | 100 | 2 | C3714506 | |
| Disease | Chronic myeloproliferative disorder | 1.87e-03 | 19 | 100 | 2 | C1292778 | |
| Disease | Familial aplasia of the vermis | 2.08e-03 | 20 | 100 | 2 | cv:C0431399 | |
| Disease | Seckel syndrome | 2.51e-03 | 22 | 100 | 2 | C0265202 | |
| Disease | Colorectal Carcinoma | 2.69e-03 | 702 | 100 | 8 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSHYKLLLQQNKKFQ | 561 | Q6ZSZ5 | |
| YQVASTLKQVKHDQQ | 61 | Q96DE5 | |
| EQQLNIYKTLKTHLI | 436 | Q92903 | |
| LQELQNLYKQNSTHT | 331 | Q9NXG0 | |
| LIQYHLTQQTKGKDT | 551 | Q5JQC9 | |
| YFKNHNVTTIIRLNK | 251 | O60729 | |
| TYVVREHQTKAKQLQ | 2006 | Q86UK0 | |
| KTYQLIHKKIIAVNN | 2261 | Q86UK0 | |
| LNSQQVEYLVRKKHI | 356 | Q8NHS2 | |
| SQLTNQQRYVLKIHL | 361 | O15123 | |
| YKQLNQQHSQIKEIE | 186 | Q9Y5C1 | |
| NKSLQLEAQTYQRIH | 376 | O95376 | |
| YFKNHNVTTIIRLNK | 221 | A4D256 | |
| LYKHAIKKRQESQQN | 1496 | O14646 | |
| IQLVKELYTDNQHLK | 661 | Q96SN8 | |
| QELQLNHLKNSITSY | 541 | Q9Y483 | |
| KYSNVIQLLHIKSNK | 116 | Q14571 | |
| IQLLHIKSNKYLTVN | 121 | Q14571 | |
| AIQSKYKIAIQHQVL | 31 | Q8TDY2 | |
| QYIQKNTITLEVHQA | 671 | Q68CZ1 | |
| QLAAKLLHIYQQSRK | 51 | Q7LDG7 | |
| QYGNVIQLLHLKSNK | 116 | Q14643 | |
| IQLLHLKSNKYLTVN | 121 | Q14643 | |
| ILRKKNNQVSFLHVY | 146 | Q9GZR5 | |
| LNQQYQKVKAQHEKI | 3846 | Q03001 | |
| YLQKVLNQQLTNHIR | 276 | Q05193 | |
| LLQVVYLHSNNITKV | 301 | P21810 | |
| QTLKHQYEEKLILLQ | 661 | O75037 | |
| NILERNQTHAIYKNT | 286 | P55259 | |
| LHLQSQKYRSNKTQT | 66 | Q6UWB1 | |
| YKKQQEQLHLQLLTQ | 146 | Q8IVH2 | |
| QYLQHKQNKAEATTV | 461 | Q9UGU5 | |
| ETKHIANAKYNQIQL | 1381 | Q7Z3U7 | |
| TIRKAQNLLKQYSQH | 271 | Q9UPT5 | |
| ILQQIQEKYDLHQVK | 111 | Q9BQG0 | |
| QEITQHLFFLQVKKQ | 111 | P35240 | |
| IKTRVKQNLLNVSYH | 346 | Q2TAC6 | |
| THQLQYLKAASQILI | 591 | O15439 | |
| HLKKVASRYQNNIKN | 271 | P49642 | |
| HQYKLKETIQKLSNV | 2366 | P04114 | |
| HQSLDTIQKTINEYK | 471 | Q9P2K1 | |
| LKTQQIKSHEYNERV | 651 | P49454 | |
| QTQFFHVKVLNINLK | 246 | Q6K0P9 | |
| KSLHVTYNQKLQQQL | 301 | Q8N5I4 | |
| QLQKKEIHLYQTFVV | 116 | P31785 | |
| IKQVLNQDLTFQHIK | 41 | Q5VWZ2 | |
| YVQKHNIQALLKDSI | 21 | P10644 | |
| GNLLKNKLHVQEQYI | 756 | Q6PJP8 | |
| YIHLSIQVNNQSKVL | 541 | P82279 | |
| THRQKLYTLQDKAQV | 1061 | P49327 | |
| LQREVLHYSQKAQEK | 1716 | Q9C0D2 | |
| LHYSQKAQEKLLVQR | 1721 | Q9C0D2 | |
| NKVTKTQNLVLYNIT | 1211 | Q6ZTR5 | |
| IHTITDNYAKNQQQK | 111 | P57054 | |
| ISNLKNLVKHAEVYN | 556 | Q02224 | |
| NHLLESKVYAKLVNN | 41 | Q4G0U5 | |
| RQTLEQKTQELYHLQ | 1206 | Q6ZN16 | |
| QKTQELYHLQLKLKS | 1211 | Q6ZN16 | |
| IIIQHYKLASKEFQN | 291 | Q8N807 | |
| VSQIQQHKDQYNLLK | 691 | O60763 | |
| YQSHLLKQILLKLNS | 326 | Q17RP2 | |
| SKNYNHKEIQLTLSL | 61 | O75674 | |
| LLKTVVRQNKNHYLL | 661 | Q9P0V3 | |
| SYQNHKITQLKIENN | 216 | Q99593 | |
| VSNVKKALRIYHEQQ | 2351 | Q5UIP0 | |
| QHLEKIAYQQKLLQE | 741 | Q6IQ23 | |
| QQKTIESLQNKSYNH | 311 | Q9H0K1 | |
| LVYNKNQHQTKNLSQ | 261 | Q02383 | |
| TLQQYRVELAEKHQK | 221 | P51692 | |
| AQHQTKLYLLNTTKL | 541 | P40692 | |
| TLQQYRVELAEKHQK | 221 | P42229 | |
| VHQQLLEYKQKISKN | 206 | A7E2S9 | |
| LQQVTENLIKKYGTH | 131 | Q9C0B6 | |
| KNLAQLNDIHQQYKI | 51 | Q9H6E4 | |
| LHYEKSLVQDVINKQ | 316 | Q8IYJ2 | |
| TKKNYRASQQEIQHI | 21 | A5YKK6 | |
| HQYSLTIEQLKQKAD | 296 | Q9H6R6 | |
| IHEKNINQLKSEVQY | 91 | Q9NNX1 | |
| NNITTGKIYQHVINK | 86 | Q9NRF8 | |
| LTVQQIEHLNKTYNT | 141 | Q16851 | |
| LQQQRQLEIYKHQKK | 571 | Q9P217 | |
| QSEVIRHYSKQAIKQ | 2841 | Q96RL7 | |
| RAFSQKQYLIKHQNI | 171 | Q3ZCT1 | |
| IQLQLFQLYHNEKKI | 221 | Q8NDV3 | |
| SAYQKSEQQRLHLLK | 1451 | Q9BX26 | |
| LIQLKQQHTLLYKVN | 166 | Q8TBR7 | |
| QEKIYFALQHVIQKN | 396 | Q92753 | |
| KAFTRVNYLTQHQKI | 306 | Q9NQX6 | |
| NLDALIQNQHKYSIK | 896 | Q8IZH2 | |
| SQKQIILLEQSYQKH | 3131 | Q709C8 | |
| RIKKKQQQQVHQVYI | 646 | Q9Y2I9 | |
| TKLQQSSYHKQQEEL | 731 | O95347 | |
| SYKELLKQLTAQQHA | 951 | O60343 | |
| KDINQLQKANVRLYH | 241 | O15195 | |
| CYEKEQQTVTKLHQL | 1141 | Q9BZF9 | |
| YQINSIQKKQLFKHS | 516 | Q9Y2K1 | |
| EIAYLNKLQQHSDKI | 571 | P33981 | |
| YKLQLKSQEIHSLQL | 1376 | Q9Y2L5 | |
| HTNNYEIIKLLVQKR | 151 | Q9UL62 | |
| LQQLHKEKYTLEQAL | 656 | Q9HAU0 | |
| HIIVAQTKDNKYTLN | 441 | Q5VZ18 | |
| ALKHNKDYQRLLQTI | 496 | Q8IYH5 | |
| KLIKQVLNVVNNIFH | 456 | Q9H0E7 | |
| LKHNSIINNYVKNSI | 226 | A8MT65 | |
| VYQSLSNSLHKVKNI | 371 | Q8IWR1 | |
| HELVYKQTKIISSNQ | 336 | Q9UHD2 | |
| RVKHNQENISSVLYK | 6296 | P20929 |